Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia.

Stem cells translational medicine

Zullo JA, Nadel EP, Rabadi MM, Baskind MJ, Rajdev MA, Demaree CM, Vasko R, Chugh SS, Lamba R, Goligorsky MS, Ratliff BB.
PMID: 25947337
Stem Cells Transl Med. 2015 Jul;4(7):852-61. doi: 10.5966/sctm.2014-0111. Epub 2015 May 06.

UNLABELLED: : We previously reported the delivery of endothelial progenitor cells (EPCs) embedded in hyaluronic acid-based (HA)-hydrogels protects renal function during acute kidney injury (AKI) and promotes angiogenesis. We attempted to further ameliorate renal dysfunction by coembedding EPCs with...

Cite
Zullo JA, Nadel EP, Rabadi MM, et al. The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia. Stem Cells Transl Med. 2015;4(7):852-61doi: 10.5966/sctm.2014-0111.
Zullo, J. A., Nadel, E. P., Rabadi, M. M., Baskind, M. J., Rajdev, M. A., Demaree, C. M., Vasko, R., Chugh, S. S., Lamba, R., Goligorsky, M. S., & Ratliff, B. B. (2015). The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia. Stem cells translational medicine, 4(7), 852-61. https://doi.org/10.5966/sctm.2014-0111
Zullo, Joseph A, et al. "The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia." Stem cells translational medicine vol. 4,7 (2015): 852-61. doi: https://doi.org/10.5966/sctm.2014-0111
Zullo JA, Nadel EP, Rabadi MM, Baskind MJ, Rajdev MA, Demaree CM, Vasko R, Chugh SS, Lamba R, Goligorsky MS, Ratliff BB. The Secretome of Hydrogel-Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia. Stem Cells Transl Med. 2015 Jul;4(7):852-61. doi: 10.5966/sctm.2014-0111. Epub 2015 May 06. PMID: 25947337; PMCID: PMC4479616.
Copy Download .nbib Format: NLM
Urinary proteomic analysis of chronic allograft nephropathy.

Proteomics. Clinical applications

O'Riordan E, Orlova TN, Mendelev N, Patschan D, Kemp R, Chander PN, Hu R, Hao G, Gross SS, Iozzo RV, Delaney V, Goligorsky MS.
PMID: 21136903
Proteomics Clin Appl. 2008 Jul;2(7):1025-35. doi: 10.1002/prca.200780137.

The pathogenesis of progressive renal allograft injury, which is termed chronic allograft nephropathy (CAN), remains obscure and is currently defined by histology. Prospective protocol-biopsy trials have demonstrated that clinical and standard laboratory tests are insufficiently sensitive indicators of the...

Cite
O'Riordan E, Orlova TN, Mendelev N, et al. Urinary proteomic analysis of chronic allograft nephropathy. Proteomics Clin Appl. 2008;2(7):1025-35doi: 10.1002/prca.200780137.
O'Riordan, E., Orlova, T. N., Mendelev, N., Patschan, D., Kemp, R., Chander, P. N., Hu, R., Hao, G., Gross, S. S., Iozzo, R. V., Delaney, V., & Goligorsky, M. S. (2008). Urinary proteomic analysis of chronic allograft nephropathy. Proteomics. Clinical applications, 2(7), 1025-35. https://doi.org/10.1002/prca.200780137
O'Riordan, Edmond, et al. "Urinary proteomic analysis of chronic allograft nephropathy." Proteomics. Clinical applications vol. 2,7 (2008): 1025-35. doi: https://doi.org/10.1002/prca.200780137
O'Riordan E, Orlova TN, Mendelev N, Patschan D, Kemp R, Chander PN, Hu R, Hao G, Gross SS, Iozzo RV, Delaney V, Goligorsky MS. Urinary proteomic analysis of chronic allograft nephropathy. Proteomics Clin Appl. 2008 Jul;2(7):1025-35. doi: 10.1002/prca.200780137. PMID: 21136903; PMCID: PMC4690473.
Copy Download .nbib Format: NLM
Perioperative implication of the endothelial glycocalyx.

Korean journal of anesthesiology

Song JW, Goligorsky MS.
PMID: 29619781
Korean J Anesthesiol. 2018 Apr;71(2):92-102. doi: 10.4097/kjae.2018.71.2.92. Epub 2018 Apr 02.

The endothelial glycocalyx (EG) is a gel-like layer lining the luminal surface of healthy vascular endothelium. Recently, the EG has gained extensive interest as a crucial regulator of endothelial funtction, including vascular permeability, mechanotransduction, and the interaction between endothelial...

Cite
Song JW, Goligorsky MS. Perioperative implication of the endothelial glycocalyx. Korean J Anesthesiol. 2018;71(2):92-102doi: 10.4097/kjae.2018.71.2.92.
Song, J. W., & Goligorsky, M. S. (2018). Perioperative implication of the endothelial glycocalyx. Korean journal of anesthesiology, 71(2), 92-102. https://doi.org/10.4097/kjae.2018.71.2.92
Song, Jong Wook, and Goligorsky, Michael S. "Perioperative implication of the endothelial glycocalyx." Korean journal of anesthesiology vol. 71,2 (2018): 92-102. doi: https://doi.org/10.4097/kjae.2018.71.2.92
Song JW, Goligorsky MS. Perioperative implication of the endothelial glycocalyx. Korean J Anesthesiol. 2018 Apr;71(2):92-102. doi: 10.4097/kjae.2018.71.2.92. Epub 2018 Apr 02. PMID: 29619781; PMCID: PMC5903118.
Copy Download .nbib Format: NLM
PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN?.

Drug discovery today. Therapeutic strategies

Chen J, Park HC, Patschan S, Brodsky SV, Gealikman O, Kuo MC, Li H, Addabbo F, Zhang F, Nasjletti A, Gross SS, Goligorsky MS.
PMID: 18496595
Drug Discov Today Ther Strateg. 2007;4(1):93-99. doi: 10.1016/j.ddstr.2007.10.006.

No abstract available.

Cite
Chen J, Park HC, Patschan S, et al. PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN?. Drug Discov Today Ther Strateg. 2007;4(1):93-99doi: 10.1016/j.ddstr.2007.10.006.
Chen, J., Park, H. C., Patschan, S., Brodsky, S. V., Gealikman, O., Kuo, M. C., Li, H., Addabbo, F., Zhang, F., Nasjletti, A., Gross, S. S., & Goligorsky, M. S. (2007). PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN?. Drug discovery today. Therapeutic strategies, 4(1), 93-99. https://doi.org/10.1016/j.ddstr.2007.10.006
Chen, Jun, et al. "PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN?." Drug discovery today. Therapeutic strategies vol. 4,1 (2007): 93-99. doi: https://doi.org/10.1016/j.ddstr.2007.10.006
Chen J, Park HC, Patschan S, Brodsky SV, Gealikman O, Kuo MC, Li H, Addabbo F, Zhang F, Nasjletti A, Gross SS, Goligorsky MS. PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN?. Drug Discov Today Ther Strateg. 2007;4(1):93-99. doi: 10.1016/j.ddstr.2007.10.006. PMID: 18496595; PMCID: PMC2390842.
Copy Download .nbib Format: NLM
Fibrogenic Secretome of Sirtuin 1-Deficient Endothelial Cells: Wnt, Notch and Glycocalyx Rheostat.

Frontiers in physiology

Lipphardt M, Dihazi H, Müller GA, Goligorsky MS.
PMID: 30298020
Front Physiol. 2018 Sep 21;9:1325. doi: 10.3389/fphys.2018.01325. eCollection 2018.

Sirtuins (SIRT) are ubiquitous histone and protein deacetylases and a member of this family, SIRT1, is the best-studied one. Its functions in endothelial cells encompass branching angiogenesis, activation of endothelial nitric oxide synthase, regulation of proapoptotic and proinflammatory pathways,...

Cite
Lipphardt M, Dihazi H, Müller GA, et al. Fibrogenic Secretome of Sirtuin 1-Deficient Endothelial Cells: Wnt, Notch and Glycocalyx Rheostat. Front Physiol. 2018;9:1325doi: 10.3389/fphys.2018.01325.
Lipphardt, M., Dihazi, H., Müller, G. A., & Goligorsky, M. S. (2018). Fibrogenic Secretome of Sirtuin 1-Deficient Endothelial Cells: Wnt, Notch and Glycocalyx Rheostat. Frontiers in physiology, 91325. https://doi.org/10.3389/fphys.2018.01325
Lipphardt, Mark, et al. "Fibrogenic Secretome of Sirtuin 1-Deficient Endothelial Cells: Wnt, Notch and Glycocalyx Rheostat." Frontiers in physiology vol. 9 (2018): 1325. doi: https://doi.org/10.3389/fphys.2018.01325
Lipphardt M, Dihazi H, Müller GA, Goligorsky MS. Fibrogenic Secretome of Sirtuin 1-Deficient Endothelial Cells: Wnt, Notch and Glycocalyx Rheostat. Front Physiol. 2018 Sep 21;9:1325. doi: 10.3389/fphys.2018.01325. eCollection 2018. PMID: 30298020; PMCID: PMC6160542.
Copy Download .nbib Format: NLM
Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool.

Aging

Yasuda K, Khandare A, Burianovskyy L, Maruyama S, Zhang F, Nasjletti A, Goligorsky MS.
PMID: 21705809
Aging (Albany NY). 2011 Jun;3(6):597-608. doi: 10.18632/aging.100341.

Although therapeutic effect of adoptive transfer of endothelial progenitor cells (EPC) has been well-substantiated, the actual engraftment is relatively low compared to a robust functional improvement of vasculopathy. Cellular mechanisms governing this action remain elusive. A recently discovered cell-cell...

Cite
Yasuda K, Khandare A, Burianovskyy L, et al. Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool. Aging (Albany NY). 2011;3(6):597-608doi: 10.18632/aging.100341.
Yasuda, K., Khandare, A., Burianovskyy, L., Maruyama, S., Zhang, F., Nasjletti, A., & Goligorsky, M. S. (2011). Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool. Aging, 3(6), 597-608. https://doi.org/10.18632/aging.100341
Yasuda, Kaoru, et al. "Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool." Aging vol. 3,6 (2011): 597-608. doi: https://doi.org/10.18632/aging.100341
Yasuda K, Khandare A, Burianovskyy L, Maruyama S, Zhang F, Nasjletti A, Goligorsky MS. Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool. Aging (Albany NY). 2011 Jun;3(6):597-608. doi: 10.18632/aging.100341. PMID: 21705809; PMCID: PMC3164368.
Copy Download .nbib Format: NLM
Biomechanical properties of endothelial glycocalyx: An imperfect pendulum.

Matrix biology plus

Jiang XZ, Goligorsky MS.
PMID: 34820618
Matrix Biol Plus. 2021 Oct 21;12:100087. doi: 10.1016/j.mbplus.2021.100087. eCollection 2021 Dec.

Endothelial glycocalyx plays a crucial role in hemodynamics in health and disease, yet studying it is met by multiple technical hindrances. We attempted to outline our views on some biomechanical properties of endothelial glycocalyx, which are potentially amenable to...

Cite
Jiang XZ, Goligorsky MS. Biomechanical properties of endothelial glycocalyx: An imperfect pendulum. Matrix Biol Plus. 2021;12:100087doi: 10.1016/j.mbplus.2021.100087.
Jiang, X. Z., & Goligorsky, M. S. (2021). Biomechanical properties of endothelial glycocalyx: An imperfect pendulum. Matrix biology plus, 12100087. https://doi.org/10.1016/j.mbplus.2021.100087
Jiang, Xi Zhuo, and Goligorsky, Michael S. "Biomechanical properties of endothelial glycocalyx: An imperfect pendulum." Matrix biology plus vol. 12 (2021): 100087. doi: https://doi.org/10.1016/j.mbplus.2021.100087
Jiang XZ, Goligorsky MS. Biomechanical properties of endothelial glycocalyx: An imperfect pendulum. Matrix Biol Plus. 2021 Oct 21;12:100087. doi: 10.1016/j.mbplus.2021.100087. eCollection 2021 Dec. PMID: 34820618; PMCID: PMC8596327.
Copy Download .nbib Format: NLM
Charting the course of renal cryoinjury.

Physiological reports

Abdulmahdi W, Zullo J, Nesi L, Goligorksy MS, Ratliff BB.
PMID: 25896979
Physiol Rep. 2015 Apr;3(4). doi: 10.14814/phy2.12357.

We sought to characterize a minor renal cryoinjury that allows investigation into renal damage processes and subsequent endogenous repair mechanisms. To achieve this, we induced a small cryoinjury to mice, in which the transient superficial application of a liquid...

Cite
Abdulmahdi W, Zullo J, Nesi L, et al. Charting the course of renal cryoinjury. Physiol Rep. 2015;3(4)doi: 10.14814/phy2.12357.
Abdulmahdi, W., Zullo, J., Nesi, L., Goligorksy, M. S., & Ratliff, B. B. (2015). Charting the course of renal cryoinjury. Physiological reports, 3(4), . https://doi.org/10.14814/phy2.12357
Abdulmahdi, Wasan, et al. "Charting the course of renal cryoinjury." Physiological reports vol. 3,4 (2015). doi: https://doi.org/10.14814/phy2.12357
Abdulmahdi W, Zullo J, Nesi L, Goligorksy MS, Ratliff BB. Charting the course of renal cryoinjury. Physiol Rep. 2015 Apr;3(4). doi: 10.14814/phy2.12357. PMID: 25896979; PMCID: PMC4425963.
Copy Download .nbib Format: NLM
The ins and outs of endothelial dysfunction: much ado about NO-thing.

Drug news & perspectives

Goligorsky MS, Gross SS.
PMID: 12819819
Drug News Perspect. 2001 Apr;14(3):133-42.

This article presents data linking eNOS function and nitric oxide (NO) generation or availability to vascular remodeling and signaling, hyperlipidemias, advanced glycated end products and hyperglycemia. These data should be viewed within the broader framework of endothelial cell dysfunction...

Cite
Goligorsky MS, Gross SS. The ins and outs of endothelial dysfunction: much ado about NO-thing. Drug News Perspect. 2001;14(3):133-42
Goligorsky, M. S., & Gross, S. S. (2001). The ins and outs of endothelial dysfunction: much ado about NO-thing. Drug news & perspectives, 14(3), 133-42.
Goligorsky, M S, and Gross, S S. "The ins and outs of endothelial dysfunction: much ado about NO-thing." Drug news & perspectives vol. 14,3 (2001): 133-42.
Goligorsky MS, Gross SS. The ins and outs of endothelial dysfunction: much ado about NO-thing. Drug News Perspect. 2001 Apr;14(3):133-42. PMID: 12819819.
Copy Download .nbib Format: NLM
Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold.

Kidney research and clinical practice

Goligorsky MS.
PMID: 26484026
Kidney Res Clin Pract. 2015 Jun;34(2):76-82. doi: 10.1016/j.krcp.2015.05.003. Epub 2015 Jun 04.

Cardiovascular complications dominate the landscape of chronic kidney diseases (CKD). Endothelial cell dysfunction (ECD) is a well-known culprit of cardiovascular morbidity and it develops in CKD with remarkable frequency. This brief overview of ECD in CKD scans two decades...

Cite
Goligorsky MS. Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold. Kidney Res Clin Pract. 2015;34(2):76-82doi: 10.1016/j.krcp.2015.05.003.
Goligorsky, M. S. (2015). Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold. Kidney research and clinical practice, 34(2), 76-82. https://doi.org/10.1016/j.krcp.2015.05.003
Goligorsky, Michael S. "Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold." Kidney research and clinical practice vol. 34,2 (2015): 76-82. doi: https://doi.org/10.1016/j.krcp.2015.05.003
Goligorsky MS. Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold. Kidney Res Clin Pract. 2015 Jun;34(2):76-82. doi: 10.1016/j.krcp.2015.05.003. Epub 2015 Jun 04. PMID: 26484026; PMCID: PMC4570605.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries